Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Gains from Investment Securities (2020 - 2025)

GoHealth's Gains from Investment Securities history spans 6 years, with the latest figure at $102000.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 31.54% year-over-year to $102000.0; the TTM value through Sep 2025 reached $3.6 million, down 3.6%, while the annual FY2024 figure was -$3000.0, 100.13% down from the prior year.
  • Gains from Investment Securities for Q3 2025 was $102000.0 at GoHealth, down from $4.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $4.8 million in Q2 2025 and bottomed at -$1.5 million in Q4 2024.
  • The 5-year median for Gains from Investment Securities is $108000.0 (2023), against an average of $426500.0.
  • The largest annual shift saw Gains from Investment Securities surged 4900.0% in 2022 before it tumbled 758.62% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $5000.0 in 2021, then soared by 4900.0% to $250000.0 in 2022, then soared by 818.0% to $2.3 million in 2023, then plummeted by 164.79% to -$1.5 million in 2024, then surged by 106.86% to $102000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Gains from Investment Securities are $102000.0 (Q3 2025), $4.8 million (Q2 2025), and $271000.0 (Q1 2025).